Panelists discuss how metabolic dysfunction drives liver injury, highlighting early recognition of the obesity–MASH connection as key to prevention.

Tetrachloroethylene exposure from everyday products increases liver fibrosis odds by 300%. The EPA restricted the chemical after health risks were discovered in blood samples.

Think one soda now and then is harmless? Think again. New data presented at United European Gastroenterology (UEG) Week shows that even consuming less than a full can of soda daily may significantly increase your risk of serious liver disease — and

Semaglutide reduced liver fibrosis and resolved MASH in the ESSENCE trial, offering dual hepatic and metabolic benefits. Read more.

Elevidys now carries a black box warning for acute liver injury and failure, limiting its use to ambulatory patients aged four and older. The FDA's actions follow fatal liver failure reports in non-ambulatory patients,